Page last updated: 2024-11-02

pindolol and Diabetes Mellitus, Adult-Onset

pindolol has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farsang, C1
Kapocsi, J1
Kiss, I1
Török, E1
Kerkovits, G1
Holló, J1
Jávor, T1
Carleo, R1
Dell'Aversano, R1
Gatti, A1
Monda, M1
Vigilante, M1
Antonucci, G1

Trials

1 trial available for pindolol and Diabetes Mellitus, Adult-Onset

ArticleYear
Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.
    American journal of hypertension, 1994, Volume: 7, Issue:7 Pt 2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Dru

1994

Other Studies

1 other study available for pindolol and Diabetes Mellitus, Adult-Onset

ArticleYear
[Effect of mepindolol on the regulation of glucose metabolism].
    Bollettino della Societa italiana di biologia sperimentale, 1987, Dec-31, Volume: 63, Issue:12

    Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Pindolo

1987